Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00578435
What this trial is testing

Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis

Who this might be right for
Genetic DisordersSickle Cell Anemia
Memorial Sloan Kettering Cancer Center 25
Very early researchEnded earlyNCT03421756
What this trial is testing

Stem Cell Transplant in Patients With Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Kathleen Dorritie 1
Not applicableStudy completedNCT03380351
What this trial is testing

Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)

Who this might be right for
Anemia, Sickle Cell
Washington University School of Medicine 17
Not applicableStudy completedNCT00076323
What this trial is testing

A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

Who this might be right for
Glucosephosphate Dehydrogenase DeficiencyFavism
Walter Reed Army Institute of Research (WRAIR) 14
Early research (Phase 1)Study completedNCT01316796
What this trial is testing

Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders

Who this might be right for
Sickle Cell AnemiaSickle Cell DiseaseChronic Hemolytic Disorders
National Heart, Lung, and Blood Institute (NHLBI) 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05456880
What this trial is testing

BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Beam Therapeutics Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT02675959
What this trial is testing

Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
New York Medical College 40
Not applicableStudy completedNCT04505969
What this trial is testing

A Study Aimed to Assess the Needs of Subjects With Sickle Cell Disease and Healthcare Professionals Managing Sickle Cell Disease Patients in Selected Nigerian Centres

Who this might be right for
Sickle Cell Disease
Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus 192
Not applicableStudy completedNCT07066072
What this trial is testing

The Radiofrequency Therapy in Management of Sickle Cell Disease Chronic Pain RCT Tested the Effect of TECAR Therapy on Sickle Cell Disease Chronic Pain.

Who this might be right for
the Use of Radiofrequency Ablation in Form of TECAR(Capacitive and Resistive Transfer Energy) in Chronic Pain of Sickle Cell Disease Patients
Cairo University 170
Testing effectiveness (Phase 2)UnknownNCT03599609
What this trial is testing

Central Nervous System Vascular Changes in Adult Sickle Cell Disease and the Effect of Treatment With Simvastatin

Who this might be right for
Sickle Cell DiseaseStroke
University of Campinas, Brazil 28
Not applicableStudy completedNCT03876821
What this trial is testing

Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research

Who this might be right for
Sickle Cell Disease
Institut National de la Santé Et de la Recherche Médicale, France 44
Testing effectiveness (Phase 2)Study completedNCT03342404
What this trial is testing

Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia

Who this might be right for
Thalassemia
Celgene 145
Not applicableStudy completedNCT00723567
What this trial is testing

A Novel Mutation of the Spectrin Gene

Who this might be right for
Hereditary Elliptocytosis (HE)Hereditary Pyropoikilocytosis (HPP)
University of Utah 12
Post-approval studies (Phase 4)Ended earlyNCT02041299
What this trial is testing

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Who this might be right for
Iron OverloadSickle Cell DiseaseOther Anemias
ApoPharma 230
Not applicableLooking for participantsNCT05799118
What this trial is testing

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia, BetaThalassemia Alpha+1 more
Cyprus Institute of Neurology and Genetics 30,000
Not applicableUnknownNCT04205123
What this trial is testing

Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Erasme University Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT05632354
What this trial is testing

GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Pfizer 47
Not applicableUnknownNCT04090268
What this trial is testing

Precision Exercise in Children With Malignant Hemopathies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more
University of Milano Bicocca 380
Testing effectiveness (Phase 2)Ended earlyNCT04247594
What this trial is testing

Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

Who this might be right for
Sickle Cell Disease
Pfizer 6
Early research (Phase 1)Study completedNCT07023029
What this trial is testing

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Who this might be right for
Healthy VolunteersSickle Cell DiseaseThalassemia
Novo Nordisk A/S 33
Next Page